Baxdrostat
CinCor Pharma
['marker ']
cincor pharma announces late-breaking presentation of phase 2 brightn data on baxdrostat in treatment-resistant hypertension at the 2022 american heart association scientific sessions - and renin biomarker activity clinically demonstrate how baxdrostat ... 
CEO Of Digital Media Online